semaglutide atrial fibrillation and Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program AF and Ozempic

2023 Apr 4;329(13):1098-1113

Notably, the study also found that longer use (over 22 weeks) was linked to weight reductions, and higher doses (around 1500 mg/day) were associated with smaller waistlines

Exclude pregnant or breastfeeding women, anyone under 18, and individuals with liver or kidney disease, bipolar or seizure disorders, or known sensitivity to B vitamins or blend components

Patient reports suggest that some women do notice alterations in their menstrual patterns whilst taking tirzepatide, but these have not been formally established in clinical studies

J Clin Biochem Nutr 72:74

Zepbound (approved November 2023) is FDA-approved specifically for chronic weight management in adults with obesity or weight-related health conditions